FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/10/2022
Back to search
Official data from USPTO
VALPHARMA GROUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
04/10/2022
Trademark type
Combined
Nice classes
5
Filing date
03/03/2020
Registration date
10/05/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/05/2021
Last transaction
10/05/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
SM
Examiner
PODESTA, GIDETTE
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a design element consisting of three leaves in blue, fuchsia, and green, next to the wording "VALPHARMA" in black, with the first "A" featuring a blue leaf, the second "A" featuring a fuchsia leaf, and the terminal "A" featuring a green leaf, the wording "VALPHARMA" being above "GROUP" in black.
Holders and representatives
Holders
EURO HOLDING S.P.A.
Representatives
James L. Scott Warner Norcross + Judd LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for skin care; Pharmaceutical preparations for use in urology and dermatology; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Medicinal preparations for the mouth to be applied in the form of capsules and tablets; Veterinary preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinaldermatologicalimmune system related diseases and disorders; Veterinary preparations for the prevention and treatment of bacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disorders; Prescription synthetic narcotics and psychotropics; sanitary preparations for medical purposes; Bacteriological preparations for medical purposes; bacteriological preparations for veterinary purposes; dietetic food and substances in the nature of herbal teasdrinksbars for medical use; dietetic foods in the nature of a paste adapted for medical or veterinary use; food for babies; herbal preparations for medical purposes; herbal preparations for veterinary purposes; dietary supplements for humans and animals; nutraceuticals for therapeutic purposes in the nature of nutritional supplements; Nutraceuticals for use as a dietary supplement for animals; Nutraceuticals for use as a dietary supplement; Nutraceutical preparations for the treatment of ocular disorders or diseasesbacteria-based diseases or disorderssleep disordersautoimmune diseases or disordersallergiesrespiratory diseasekidney diseases or disordersdiabetes; Nutraceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Probiotic supplements; dietary and nutritional supplements; medicated food supplements; medical plasters; materials for dressings in the nature of gauze for dressingwadding for dressings
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/17/2022
FIMP
FINAL DISPOSITION PROCESSED
03/16/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/20/2021
PUBO
PUBLISHED FOR OPPOSITION
07/20/2021
GPNX
NOTIFICATION PROCESSED BY IB
07/18/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/30/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/30/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/10/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/09/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/05/2021
GNFR
FINAL REFUSAL E-MAILED
01/05/2021
CNFR
FINAL REFUSAL WRITTEN
01/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/29/2020
RFNT
REFUSAL PROCESSED BY IB
07/18/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/29/2020
RFRR
REFUSAL PROCESSED BY MPU
06/29/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/28/2020
CNRT
NON-FINAL ACTION WRITTEN
05/27/2020
DOCK
ASSIGNED TO EXAMINER
05/20/2020
MAFR
APPLICATION FILING RECEIPT MAILED
05/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/01/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/30/2020
Continuous trademark protection
Get notified about every new filing that threatens VALPHARMA GROUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.